91281-32-2 Usage
Description
N-ACETYL-4-S-CYSTEAMINYLPHENOL, also known as N-2-[(4-Hydroxyphenyl)sulfanyl]ethylacetamide, is a chemical compound with the CAS number 91281-32-2. It is characterized by its unique structure that includes a 4-hydroxyphenyl group connected to a sulfanylethyl moiety, which is further linked to an acetamide group. N-ACETYL-4-S-CYSTEAMINYLPHENOL has potential applications in various fields, particularly in the cosmetic industry.
Uses
Used in Cosmetic Industry:
N-ACETYL-4-S-CYSTEAMINYLPHENOL is used as a skin-lightening agent for its ability to reduce the appearance of pigmentation and even out skin tone. It is particularly effective in cosmetic formulations due to its ability to inhibit melanin production, which is responsible for the color of the skin. By regulating melanin synthesis, this compound can help address various skin concerns such as hyperpigmentation, age spots, and uneven skin tone, making it a valuable ingredient in skincare products.
Check Digit Verification of cas no
The CAS Registry Mumber 91281-32-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,2,8 and 1 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 91281-32:
(7*9)+(6*1)+(5*2)+(4*8)+(3*1)+(2*3)+(1*2)=122
122 % 10 = 2
So 91281-32-2 is a valid CAS Registry Number.
InChI:InChI=1/C10H13NO2S/c1-8(12)11-6-7-14-10-4-2-9(13)3-5-10/h2-5,13H,6-7H2,1H3,(H,11,12)
91281-32-2Relevant articles and documents
Antihypertensive activities of phenyl aminoethyl sulfides, a class of synthetic substrates for dopamine β-hydroxylase
Padgette,Herman,Hee Han,et al.
, p. 1354 - 1357 (2007/10/02)
Four sulfur-containing analogues of phenylpropylamine were synthesized and evaluated as substrates for dopamine β-hydroxylase (DBH) and monoamine oxidase (MAO). All four phenyl aminoethyl sulfides were shown to be good substrates for DBH whereas only the two analogues not possessing a methyl group α to the terminal amino group were substrates for MAO. All four analogues were tested for acute antihypertensive activity in an animal model for hypertension, the spontaneously hypertensive rat (SHR). Two of the analogues, both of which should partition readily across the blood-brain barrier, did not appreciably reduce systemic blood pressure in the 6-h testing period. However, the two analogues that were designed to be relatively restricted to peripheral sites of action caused a dramatic drop in blood pressure in SHR of 25% within 1-1.5-h postinjection, with the analogue designed to be both restricted to the periphery and MAO inactive, causing a more prolonged antihypertensive activity.
